UC BRAID Center for Accelerated Innovation

UC BRAID 加速创新中心

• 批准号: 8573647
• 负责人: MICHAEL J PALAZZOLO
• 金额: $ 119.92万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-26 至 2020-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8573647
• 关键词: Acceleration; Accounting; Address; Award; Biomedical Engineering; Biomedical Research; Businesses; California; Capital; Clinical Research; Clinical Sciences; Creativeness; Development; Devices; Diagnostic; Ecosystem; Engineering; Funding; Grant; Health; Health Sciences; Heart Diseases; Hematological Disease; Incubated; Industry; Joints; Los Angeles; Lung diseases; Medical; Mentorship; Mission; Modeling; National Heart, Lung, and Blood Institute; Nonprofit Organizations; Patient Care; Patients; Research; Research Infrastructure; Research Institute; San Francisco; Staging; System; Technology; Therapeutic; Training and Education; Translational Research; Translations; Universities; abstracting; design; improved; innovation; medical schools; programs

DESCRIPTION (provided by applicant): The University of California Center for Accelerated Innovation proposes to create new mechanisms and to leverage its diverse strengths in diagnostics, therapeutics, and devices to support translation of promising early-stage inventions for patient benefit. The Center is a consortium of the five UC medical campuses: UC Davis, UC Irvine, UC Los Angeles, UC San Diego, and UC San Francisco. Each campus has a thriving research enterprise, nationally ranked medical school, and translational research institute funded by Clinical and Translational Science Awards (CTSA). Together, our five campuses account for nearly 7% of NHLBI's grant funding. The Center taps into the vigor and creativity of California's legendary biomedical and engineering ecosystem and integrates the many successful business, engineering and health sciences programs at our campuses. Our program will partner with well-established biomedical companies, venture capital firms, industry organizations and nonprofits focused on medical innovation. The Center is supported by UC Biomedical Research Acceleration, Integration, and Development (UC BRAID), a joint effort of the five UC biomedical campuses designed to catalyze and accelerate biomedical, clinical, and translational research across the UC system. Together we will: 1) Engage University of California heart, lung and blood disease innovators in entrepreneurism through a comprehensive education, training and mentorship program. 2) Solicit and select technologies with high commercial potential that align with NHLBI's mission and address unmet medical needs or significant scientific opportunity. 3) Incubate our most promising technologies in accordance with industry requirements to facilitate their translation to commercial products that improve patient care and enhance health. 4) Create a high-performing, sustainable infrastructure that will serve as a model to academic research centers. These programs will create an integrated, sustainable infrastructure to accelerate the translation of our NHLBI-funded discoveries to the marketplace in order to promote health and improve patient care. (End of Abstract)

描述（由申请人提供）： 加利福尼亚大学加速创新中心提议创建新的机制，并利用其在诊断，治疗学和设备方面的多种优势，以支持有前途的早期发明的翻译，以供患者利益。该中心是五个UC医疗校园的财团：UC Davis，UC Irvine，UC洛杉矶分校，加州大学圣地亚哥分校和加州大学旧金山加州大学。每个校园都有一个蓬勃发展的研究企业，全国排名的医学院，以及由临床和转化科学奖（CTSA）资助的转化研究所。我们的五个校园共同占NHLBI赠款资金的近7％。该中心攻入加利福尼亚州传奇的生物医学和工程生态系统的活力和创造力，并将许多成功的商业，工程和健康科学计划整合在我们的校园中。我们的计划将与建立良好的生物医学公司，风险投资公司，行业组织和非营利组织合作。该中心得到了UC生物医学研究的加速，整合和开发（UC Braid）的支持，这是五个UC生物医学校园的共同努力，旨在催化和加速整个UC系统的生物医学，临床和转化研究。我们将共同：1）通过全面的教育，培训和指导计划与加利福尼亚大学心脏，肺和血液疾病创新者一起参与企业家精神。 2）与NHLBI的使命相吻合，并满足未满足的医疗需求或巨大的科学机会，征求和精选的技术具有很高的商业潜力。 3）根据行业要求孵化我们最有前途的技术，以促进其转化为改善患者护理并改善健康的商业产品。 4）创建一个高性能，可持续的基础设施，该基础设施将成为学术研究中心的典范。这些计划将创建一个综合，可持续的基础设施，以加速我们NHLBI资助的发现到市场的转换，以促进健康并改善患者护理。 （抽象的结尾）